Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy

Continuous high doses of radiation can cause irreversible side effects and radiation resistance; thus, advanced radiosensitizers are urgently needed. To overcome this problem, we developed a nano platelet radiosensitization system (PCA) by coating the chemotherapeutic drug cisplatin (CDDP) loaded go...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mingzhu Chen, Ping Wang, Dazhen Jiang, Zhirong Bao, Hong Quan
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/9fb4a9b552f34f1ead41e0f8fc7af4fe
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9fb4a9b552f34f1ead41e0f8fc7af4fe
record_format dspace
spelling oai:doaj.org-article:9fb4a9b552f34f1ead41e0f8fc7af4fe2021-11-30T17:49:28ZPlatelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy2234-943X10.3389/fonc.2021.793006https://doaj.org/article/9fb4a9b552f34f1ead41e0f8fc7af4fe2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.793006/fullhttps://doaj.org/toc/2234-943XContinuous high doses of radiation can cause irreversible side effects and radiation resistance; thus, advanced radiosensitizers are urgently needed. To overcome this problem, we developed a nano platelet radiosensitization system (PCA) by coating the chemotherapeutic drug cisplatin (CDDP) loaded gold nanocages (AuNs) within the platelet membrane. The developed PCA system may enable AuNs to have immune escape and targeting capabilities. After administration, PCA will actively target tumor cells and avoid being cleared by the immune system. Subsequently, CDDP, which destroys tumor cell DNA, can not only kill tumor cells directly but also combine with AuNs, which deposit radiation energy into tumor tissues, reducing RT resistance. In vivo and in vitro studies revealed that the combination of PCA with RT (2Gy) efficiently inhibits tumor proliferation without causing side effects such as inflammation. To conclude, this is the first attempt to use platelet membranes to correctly transport AuNs while also accomplishing low-dose RT, which could help AuNs-based tumor RT become more effective.Mingzhu ChenPing WangDazhen JiangZhirong BaoHong QuanFrontiers Media S.A.articleplatelet membranesgold nanocagesdrug deliverylow-dose radiotherapycisplatinNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic platelet membranes
gold nanocages
drug delivery
low-dose radiotherapy
cisplatin
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle platelet membranes
gold nanocages
drug delivery
low-dose radiotherapy
cisplatin
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Mingzhu Chen
Ping Wang
Dazhen Jiang
Zhirong Bao
Hong Quan
Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy
description Continuous high doses of radiation can cause irreversible side effects and radiation resistance; thus, advanced radiosensitizers are urgently needed. To overcome this problem, we developed a nano platelet radiosensitization system (PCA) by coating the chemotherapeutic drug cisplatin (CDDP) loaded gold nanocages (AuNs) within the platelet membrane. The developed PCA system may enable AuNs to have immune escape and targeting capabilities. After administration, PCA will actively target tumor cells and avoid being cleared by the immune system. Subsequently, CDDP, which destroys tumor cell DNA, can not only kill tumor cells directly but also combine with AuNs, which deposit radiation energy into tumor tissues, reducing RT resistance. In vivo and in vitro studies revealed that the combination of PCA with RT (2Gy) efficiently inhibits tumor proliferation without causing side effects such as inflammation. To conclude, this is the first attempt to use platelet membranes to correctly transport AuNs while also accomplishing low-dose RT, which could help AuNs-based tumor RT become more effective.
format article
author Mingzhu Chen
Ping Wang
Dazhen Jiang
Zhirong Bao
Hong Quan
author_facet Mingzhu Chen
Ping Wang
Dazhen Jiang
Zhirong Bao
Hong Quan
author_sort Mingzhu Chen
title Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy
title_short Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy
title_full Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy
title_fullStr Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy
title_full_unstemmed Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy
title_sort platelet membranes coated gold nanocages for tumor targeted drug delivery and amplificated low-dose radiotherapy
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/9fb4a9b552f34f1ead41e0f8fc7af4fe
work_keys_str_mv AT mingzhuchen plateletmembranescoatedgoldnanocagesfortumortargeteddrugdeliveryandamplificatedlowdoseradiotherapy
AT pingwang plateletmembranescoatedgoldnanocagesfortumortargeteddrugdeliveryandamplificatedlowdoseradiotherapy
AT dazhenjiang plateletmembranescoatedgoldnanocagesfortumortargeteddrugdeliveryandamplificatedlowdoseradiotherapy
AT zhirongbao plateletmembranescoatedgoldnanocagesfortumortargeteddrugdeliveryandamplificatedlowdoseradiotherapy
AT hongquan plateletmembranescoatedgoldnanocagesfortumortargeteddrugdeliveryandamplificatedlowdoseradiotherapy
_version_ 1718406397863919616